Answers are grounded in this paper and cite their sources.
Monitoring of CLB and nCLB levels is necessary for clinical care of patients concomitantly on CLB and CBD. Nonetheless, CBD is a safe and effective treatment of refractory epilepsy in patients receiving CLB treatment.
No takes yet. Share an insight, caveat, or question.
Geffrey et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: